Home > Insider Trading > Filing (0001209191-16-133865)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389072	Heartware International Inc.	HTWR	Surgical & Medical Instruments & Apparatus (3841)	980498958

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615034	Mark Strong	C/O Heartware International, Inc. 500 Old Connecticut Path Framingham MA 01701	Senior Vp, R&D And Quality	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-07-21	2,500	$0.00	5,388	No	4	M	Direct
Common Stock	Disposition	2016-07-22	814	$57.71	4,574	No	4	S	Direct
Common Stock	Disposition	2016-07-22	1,061	$57.71	3,513	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2016-07-21	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,053	2016-07-21	2016-07-21	No	4	M	Direct

Footnotes

On September 9, 2014, the reporting person was granted restricted stock units to acquire 10,000 shares of HeartWare International common stock. The award vests in four equal installments on July 21, 2015, July 21, 2016, July 21, 2017 and July 21, 2018. On July 21, 2016, 2,500 shares of common stock were issued to the reporting person.
These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The sale proceeds were utilized to pay taxes related to the vesting of restricted stock units and receipt of the related shares reported on this Form 4.
This price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from 57.65 to 57.74. The reporting person has provided the issuer and will provide any security holder of the issuer or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
These shares were sold pursuant to a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.